DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
EVOCALCET
3
Small molecule
Investigational
Unknown
Unknown
Hyperparathyroidism; Hyperparathyroidism, Secondary
Calcium sensing receptor positive allosteric modulator
EVOCALCET
×
Maximum Phase:
3
First Approval:
None
UNII:
E58MLH082P
Molecule Type:
Small molecule
Molecular Formula:
C24H26N2O2
Molecular Weight:
374.48
AlogP:
4.4
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CADAZOLID
3
Small molecule
Investigational
Unknown
Unknown
Clostridium Infections
Bacterial 70S ribosome inhibitor
CADAZOLID
×
Maximum Phase:
3
First Approval:
None
UNII:
2OEA2UN10Y
Molecule Type:
Small molecule
Molecular Formula:
C29H29F2N3O8
Molecular Weight:
585.56
AlogP:
3.04
PSA:
141.77
HBD:
3.0
HBA:
#RotB:
8.0
Source:
TASISULAM SODIUM
3
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
TASISULAM SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
O3955SHR9J
Molecule Type:
Small molecule
Molecular Formula:
C11H5BrCl2NNaO3S2
Molecular Weight:
437.1
AlogP:
3.94
PSA:
63.24
HBD:
1.0
HBA:
#RotB:
3.0
Source:
M-FLUOROBENZYLGUANIDINE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
M-FLUOROBENZYLGUANIDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C8H10FN3
Molecular Weight:
167.19
AlogP:
0.81
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
RELAMORELIN
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Ghrelin receptor agonist
RELAMORELIN
×
Maximum Phase:
3
First Approval:
None
UNII:
BIW199E18V
Molecule Type:
Small molecule
Molecular Formula:
C43H50N8O5S
Molecular Weight:
790.99
AlogP:
2.59
PSA:
199.34
HBD:
8.0
HBA:
#RotB:
15.0
Source:
RUBOXISTAURIN
3
Small molecule
Investigational
Unknown
Unknown
Heart Failure; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diabetic Retinopathy
Protein kinase C beta inhibitor
RUBOXISTAURIN
×
Maximum Phase:
3
First Approval:
None
UNII:
721809WQCP
Molecule Type:
Small molecule
Molecular Formula:
C28H28N4O3
Molecular Weight:
468.56
AlogP:
3.51
PSA:
68.5
HBD:
1.0
HBA:
#RotB:
2.0
Source:
APLAVIROC
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
APLAVIROC
×
Maximum Phase:
3
First Approval:
None
UNII:
98B425P30V
Molecule Type:
Small molecule
Molecular Formula:
C33H43N3O6
Molecular Weight:
577.72
AlogP:
4.58
PSA:
119.41
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MEDETOMIDINE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MEDETOMIDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
MR15E85MQM
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2
Molecular Weight:
200.28
AlogP:
3.18
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
POLYFEROSE
3
Small molecule
Investigational
Unknown
Unknown
Anemia, Iron-Deficiency
Unknown
POLYFEROSE
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLINABULIN
3
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Non-Small-Cell Lung; Neutropenia
Tubulin inhibitor
PLINABULIN
×
Maximum Phase:
3
First Approval:
None
UNII:
986FY7F8XR
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O2
Molecular Weight:
336.4
AlogP:
0.74
PSA:
94.4
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ISAVUCONAZOLE
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Leukemia, Myeloid, Acute; Lymphoma; Myeloproliferative Disorders; Aspergillosis; Candidemia; Mycoses
Unknown
ISAVUCONAZOLE
×
Maximum Phase:
3
First Approval:
None
UNII:
60UTO373KE
Molecule Type:
Small molecule
Molecular Formula:
C22H17F2N5OS
Molecular Weight:
437.48
AlogP:
4.24
PSA:
87.62
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CILOMILAST
3
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Phosphodiesterase 4 inhibitor
CILOMILAST
×
Maximum Phase:
3
First Approval:
None
UNII:
8ATB1C1R6X
Molecule Type:
Small molecule
Molecular Formula:
C20H25NO4
Molecular Weight:
343.42
AlogP:
4.05
PSA:
79.55
HBD:
1.0
HBA:
#RotB:
5.0
Source:
APAZIQUONE
3
Small molecule
Investigational
Unknown
Unknown
Urinary Bladder Neoplasms
DNA inhibitor
APAZIQUONE
×
Maximum Phase:
3
First Approval:
None
UNII:
H464ZO600O
Molecule Type:
Small molecule
Molecular Formula:
C15H16N2O4
Molecular Weight:
288.3
AlogP:
0.1
PSA:
82.54
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FLINDOKALNER
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Calcium-activated potassium channel subunit alpha-1 opener
FLINDOKALNER
×
Maximum Phase:
3
First Approval:
None
UNII:
J57O328W4W
Molecule Type:
Small molecule
Molecular Formula:
C16H10ClF4NO2
Molecular Weight:
359.71
AlogP:
4.53
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CS-3150
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CS-3150
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EXATECAN
3
Small molecule
Investigational
Unknown
Unknown
Unknown
DNA topoisomerase I inhibitor
EXATECAN
×
Maximum Phase:
3
First Approval:
None
UNII:
OC71PP0F89
Molecule Type:
Small molecule
Molecular Formula:
C24H22FN3O4
Molecular Weight:
435.46
AlogP:
2.47
PSA:
107.44
HBD:
2.0
HBA:
#RotB:
1.0
Source:
BARASERTIB
3
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid; Lymphoma; Neoplasms; Leukemia, Myeloid, Acute
Serine/threonine-protein kinase Aurora-B inhibitor
BARASERTIB
×
Maximum Phase:
3
First Approval:
None
UNII:
16XC2U7W8N
Molecule Type:
Small molecule
Molecular Formula:
C26H31FN7O6P
Molecular Weight:
587.55
AlogP:
3.62
PSA:
174.82
HBD:
5.0
HBA:
#RotB:
15.0
Source:
VIPIVOTIDE TETRAXETAN LUTETIUM LU-177
3
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
VIPIVOTIDE TETRAXETAN LUTETIUM LU-177
×
Maximum Phase:
3
First Approval:
None
UNII:
G6UF363ECX
Molecule Type:
Small molecule
Molecular Formula:
C49H68LuN9O16
Molecular Weight:
1216.07
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TOLEBRUTINIB
3
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
Unknown
TOLEBRUTINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H25N5O3
Molecular Weight:
455.52
AlogP:
3.91
PSA:
95.38
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TELCAGEPANT
3
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Calcitonin gene-related peptide type 1 receptor antagonist
TELCAGEPANT
×
Maximum Phase:
3
First Approval:
None
UNII:
D42O649ALL
Molecule Type:
Small molecule
Molecular Formula:
C26H27F5N6O3
Molecular Weight:
566.53
AlogP:
4.1
PSA:
103.59
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BRIVANIB
3
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Uterine Cervical Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Liver Neoplasms
Fibroblast growth factor receptor inhibitor
BRIVANIB
×
Maximum Phase:
3
First Approval:
None
UNII:
DDU33B674I
Molecule Type:
Small molecule
Molecular Formula:
C19H19FN4O3
Molecular Weight:
370.38
AlogP:
3.52
PSA:
84.67
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TC-5214
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TC-5214
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZICRONAPINE
3
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ZICRONAPINE
×
Maximum Phase:
3
First Approval:
None
UNII:
QZV11V7G6A
Molecule Type:
Small molecule
Molecular Formula:
C22H27ClN2
Molecular Weight:
354.93
AlogP:
4.94
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
2.0
Source:
BRINCIDOFOVIR
3
Small molecule
Investigational
Unknown
Unknown
Adenovirus Infections, Human; Hemorrhagic Fever, Ebola; Virus Diseases; Adenoviridae Infections; Cytomegalovirus Infections; Smallpox
DNA polymerase inhibitor
BRINCIDOFOVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
6794O900AX
Molecule Type:
Small molecule
Molecular Formula:
C27H52N3O7P
Molecular Weight:
561.7
AlogP:
5.25
PSA:
146.13
HBD:
3.0
HBA:
#RotB:
26.0
Source:
FOLITIXORIN CALCIUM
3
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colonic Neoplasms; Rectal Neoplasms
Unknown
FOLITIXORIN CALCIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
E24OC39JVA
Molecule Type:
Small molecule
Molecular Formula:
C20H21CaN7O6
Molecular Weight:
495.51
AlogP:
-0.52
PSA:
193.98
HBD:
6.0
HBA:
#RotB:
7.0
Source:
CRENOLANIB
3
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Stomach Neoplasms; Glioblastoma; Glioma; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute
Platelet-derived growth factor receptor inhibitor
CRENOLANIB
×
Maximum Phase:
3
First Approval:
None
UNII:
LQF7I567TQ
Molecule Type:
Small molecule
Molecular Formula:
C26H29N5O2
Molecular Weight:
443.55
AlogP:
3.92
PSA:
78.43
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TRIPTOLIDE
3
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Infections; Polycystic Kidney, Autosomal Dominant
Unknown
TRIPTOLIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
19ALD1S53J
Molecule Type:
Small molecule
Molecular Formula:
C20H24O6
Molecular Weight:
360.41
AlogP:
1.1
PSA:
84.12
HBD:
1.0
HBA:
#RotB:
1.0
Source:
OTAMIXABAN
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Liver Diseases; Coronary Disease; Acute Coronary Syndrome
Coagulation factor X inhibitor
OTAMIXABAN
×
Maximum Phase:
3
First Approval:
None
UNII:
S173RED00L
Molecule Type:
Small molecule
Molecular Formula:
C25H26N4O4
Molecular Weight:
446.51
AlogP:
2.42
PSA:
132.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CANFOSFAMIDE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
DNA disrupting agent
CANFOSFAMIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
1RS284BFUI
Molecule Type:
Small molecule
Molecular Formula:
C26H40Cl4N5O10PS
Molecular Weight:
787.48
AlogP:
1.7
PSA:
225.74
HBD:
5.0
HBA:
#RotB:
25.0
Source:
PEFICITINIB
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Liver Diseases; Colitis, Ulcerative; Psoriasis; Arthritis, Rheumatoid
Janus Kinase (JAK) inhibitor
PEFICITINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
HPH1166CKX
Molecule Type:
Small molecule
Molecular Formula:
C18H22N4O2
Molecular Weight:
326.4
AlogP:
2.01
PSA:
104.03
HBD:
4.0
HBA:
#RotB:
3.0
Source:
ONO-5920
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ONO-5920
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SURAMIN
3
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
SURAMIN
×
Maximum Phase:
3
First Approval:
None
UNII:
6032D45BEM
Molecule Type:
Small molecule
Molecular Formula:
C51H40N6O23S6
Molecular Weight:
1297.3
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OZAGREL
3
Small molecule
Investigational
Unknown
Unknown
Dry Eye Syndromes
Thromboxane-A synthase inhibitor
OZAGREL
×
Maximum Phase:
3
First Approval:
None
UNII:
L256JB984D
Molecule Type:
Small molecule
Molecular Formula:
C13H12N2O2
Molecular Weight:
228.25
AlogP:
2.03
PSA:
55.12
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FIBOFLAPON SODIUM
3
Small molecule
Investigational
Unknown
Unknown
HIV-Associated Lipodystrophy Syndrome; Asthma; Cystic Fibrosis
5-lipoxygenase activating protein inhibitor
FIBOFLAPON SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
75YS00XOG3
Molecule Type:
Small molecule
Molecular Formula:
C38H42N3NaO4S
Molecular Weight:
659.83
AlogP:
8.98
PSA:
86.47
HBD:
1.0
HBA:
#RotB:
12.0
Source:
SR121463B
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SR121463B
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
153
154
155
156
157
158
159
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA